Clinical Trials
6
Active:0
Completed:5
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
Phase 4
Recruiting
- Conditions
- Cataract
- Interventions
- Device: Clareon PanOptixDrug: Mix-and-Match PanOptix/VivityDrug: Clareon PanOptix PRO
- First Posted Date
- 2025-04-10
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Berkeley Eye Center
- Target Recruit Count
- 320
- Registration Number
- NCT06922084
- Locations
- 🇺🇸
Shafer Vision Institute, Plymouth Meeting, Pennsylvania, United States
🇺🇸Berkeley Eye Center, Houston, Texas, United States
Visual Outcomes and Patient Satisfaction With Vivity IOL in Post Refractive Patients
Completed
- Conditions
- Pseudophakia
- First Posted Date
- 2023-10-03
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Berkeley Eye Center
- Target Recruit Count
- 20
- Registration Number
- NCT06064916
- Locations
- 🇺🇸
Berkeley Eye Center, Houston, Texas, United States
Assessment of Measurement Variability Across Automated Biometry Devices
Completed
- Conditions
- Myopia
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Berkeley Eye Center
- Target Recruit Count
- 204
- Registration Number
- NCT06045325
- Locations
- 🇺🇸
Berkeley Eye Center, Houston, Texas, United States
Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy
Completed
- Conditions
- Pseudophakia
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Berkeley Eye Center
- Target Recruit Count
- 230
- Registration Number
- NCT06041139
- Locations
- 🇺🇸
Berkeley Eye Center, Houston, Texas, United States
Maximizing Visual Outcomes With Eyhance IOLs
Completed
- Conditions
- Pseudophakia
- First Posted Date
- 2022-11-09
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Berkeley Eye Center
- Target Recruit Count
- 110
- Registration Number
- NCT05611073
- Locations
- 🇺🇸
Berkeley Eye Center, Houston, Texas, United States
- Prev
- 1
- 2
- Next
News
No news found